These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12676817)

  • 1. Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families.
    Veldkamp MW; Wilders R; Baartscheer A; Zegers JG; Bezzina CR; Wilde AA
    Circ Res; 2003 May; 92(9):976-83. PubMed ID: 12676817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinus Bradycardia in Carriers of the SCN5A-1795insD Mutation: Unraveling the Mechanism through Computer Simulations.
    Wilders R
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
    Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
    Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential calcium sensitivity in Na
    Abdelsayed M; Baruteau AE; Gibbs K; Sanatani S; Krahn AD; Probst V; Ruben PC
    J Physiol; 2017 Sep; 595(18):6165-6186. PubMed ID: 28734073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
    Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
    J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
    Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
    Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Na+ channels promote pause-induced spontaneous diastolic activity in long QT syndrome type 3 myocytes.
    Fredj S; Lindegger N; Sampson KJ; Carmeliet P; Kass RS
    Circ Res; 2006 Nov; 99(11):1225-32. PubMed ID: 17082480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
    Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
    J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate-dependent QT shortening mechanism for the LQT3 deltaKPQ mutant.
    Nagatomo T; January CT; Ye B; Abe H; Nakashima Y; Makielski JC
    Cardiovasc Res; 2002 Jun; 54(3):624-9. PubMed ID: 12031708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tachy- or bradyarrhythmias: implications for therapeutic intervention in LQT3 families.
    Glatter KA; Chiamvimonvat N
    Circ Res; 2003 May; 92(9):941-3. PubMed ID: 12750302
    [No Abstract]   [Full Text] [Related]  

  • 12. Temperature dependence of early and late currents in human cardiac wild-type and long Q-T DeltaKPQ Na+ channels.
    Nagatomo T; Fan Z; Ye B; Tonkovich GS; January CT; Kyle JW; Makielski JC
    Am J Physiol; 1998 Dec; 275(6):H2016-24. PubMed ID: 9843800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome.
    Wang DW; Yazawa K; George AL; Bennett PB
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13200-5. PubMed ID: 8917568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction.
    Chen J; Makiyama T; Wuriyanghai Y; Ohno S; Sasaki K; Hayano M; Harita T; Nishiuchi S; Yuta Yamamoto ; Ueyama T; Shimizu A; Horie M; Kimura T
    Heart Rhythm; 2016 Jan; 13(1):289-98. PubMed ID: 26282245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of neuronal- and cardiac-type sodium channels for murine sinoatrial node pacemaking.
    Lei M; Jones SA; Liu J; Lancaster MK; Fung SS; Dobrzynski H; Camelliti P; Maier SK; Noble D; Boyett MR
    J Physiol; 2004 Sep; 559(Pt 3):835-48. PubMed ID: 15254155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome.
    Makita N; Behr E; Shimizu W; Horie M; Sunami A; Crotti L; Schulze-Bahr E; Fukuhara S; Mochizuki N; Makiyama T; Itoh H; Christiansen M; McKeown P; Miyamoto K; Kamakura S; Tsutsui H; Schwartz PJ; George AL; Roden DM
    J Clin Invest; 2008 Jun; 118(6):2219-29. PubMed ID: 18451998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic mechanism of the enhanced rate-dependent QT shortening in the R1623Q mutant of the LQT3 syndrome.
    Oginosawa Y; Nagatomo T; Abe H; Makita N; Makielski JC; Nakashima Y
    Cardiovasc Res; 2005 Jan; 65(1):138-47. PubMed ID: 15621041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited Brugada and long QT-3 syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes.
    Rivolta I; Abriel H; Tateyama M; Liu H; Memmi M; Vardas P; Napolitano C; Priori SG; Kass RS
    J Biol Chem; 2001 Aug; 276(33):30623-30. PubMed ID: 11410597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD.
    Remme CA; Verkerk AO; Nuyens D; van Ginneken AC; van Brunschot S; Belterman CN; Wilders R; van Roon MA; Tan HL; Wilde AA; Carmeliet P; de Bakker JM; Veldkamp MW; Bezzina CR
    Circulation; 2006 Dec; 114(24):2584-94. PubMed ID: 17145985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
    Nasilli G; Yiangou L; Palandri C; Cerbai E; Davis RP; Verkerk AO; Casini S; Remme CA
    Europace; 2023 Jun; 25(6):. PubMed ID: 37369559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.